Free provider profile
TREVER KREHBIEL, MD
NPI 1720284250
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2026-02-26.
3595 N WEBB RD, WICHITA, KS, 67226
316-260-8700
10 practice locations listed
Enumerated 2007-06-22
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 10 practice locations listed — multi-site footprint.
- — Record updated within the last year.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,462
Medicare patients
144
Part D drug cost
$354,191
Brand-name share
11.9%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Invega Sustenna (Paliperidone Palmitate) | 37 | $115,195 |
| Risperdal Consta (Risperidone Microspheres) | 27 | $25,224 |
| Rexulti (Brexpiprazole) | 16 | $22,673 |
| Vraylar (Cariprazine Hcl) | 14 | $20,090 |
| Risperidone Er (Risperidone Microspheres) | 20 | $15,222 |
| Olanzapine Odt (Olanzapine) | 13 | $7,743 |
| Paliperidone Er (Paliperidone) | 39 | $3,687 |
| Duloxetine Hcl (Duloxetine Hcl) | 73 | $2,894 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024490 sessions · 26 patients · $419,998
2023392 sessions · 17 patients · $329,349
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.